Immediate Impact
29 standout
Citing Papers
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Marcelo Capra being referenced
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY
2020
Pharmacokinetics and Exposure–Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marcelo Capra | 204 | 189 | 37 | 124 | 38 | 317 | |
| Margherita Girino | 108 | 98 | 32 | 116 | 31 | 345 | |
| Sung‐Soo Yoon | 146 | 88 | 33 | 118 | 51 | 260 | |
| Alexander B. Sibley | 95 | 164 | 46 | 113 | 26 | 370 | |
| Wanda Knopińska‐Posłuszny | 104 | 108 | 119 | 50 | 37 | 321 | |
| Vladimir Vorobyev | 217 | 133 | 43 | 178 | 37 | 360 | |
| Mercedes Gironella | 186 | 141 | 70 | 125 | 45 | 335 | |
| Danai Dima | 163 | 206 | 54 | 154 | 66 | 351 | |
| Saulius Girnius | 85 | 71 | 10 | 186 | 35 | 280 | |
| Richard Mansour | 58 | 150 | 45 | 40 | 54 | 314 | |
| Yasser Abou Mourad | 145 | 178 | 37 | 64 | 40 | 337 |
All Works
Login with ORCID to disown or claim papers
Loading papers...